Literature DB >> 8874111

The frequency of resistance to erythromycin in group A streptococci in Ankara.

A E Kürekçi1, M Baysallar, A Karaarslan, G Emekdaş, V Köseoğlu, R Akin, O Ozcan.   

Abstract

UNLABELLED: The frequency of resistance to erythromycin of group A beta-haemolytic streptococci in the last 7 years was determined in three medical centres in Ankara. While all group A beta-haemolytic streptococci strains were susceptible to penicillin, a gradual increase in resistance to erythromycin until 1992 was observed. However, a substantial increase in erythromycin resistance occurred in 1993 when newer macrolides became available and were widely used in the latter part of 1992.
CONCLUSION: The data show that frequent testing for resistance to erythromycin of group A beta-haemolytic streptococci is required for the use of this antibiotic in our country.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8874111     DOI: 10.1007/bf02002906

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  25 in total

1.  Resistance to erythromycin in group A streptococci.

Authors:  H Seppälä; A Nissinen; H Järvinen; S Huovinen; T Henriksson; E Herva; S E Holm; M Jahkola; M L Katila; T Klaukka
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

2.  The resurgence of group A streptococcal infections and their sequelae.

Authors:  E L Kaplan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

3.  Erythromycin-resistant Streptococcus pyogenes.

Authors:  G Phillips; D Parratt; G V Orange; I Harper; H McEwan; N Young
Journal:  J Antimicrob Chemother       Date:  1990-04       Impact factor: 5.790

4.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

5.  Decline of erythromycin resistance of group A beta-hemolytic streptococci in Japan. Comparison with worldwide reports.

Authors:  J W Bass; M E Weisse; M R Plymyer; S Murphy; B J Eberly
Journal:  Arch Pediatr Adolesc Med       Date:  1994-01

6.  Erythromycin-resistant group A beta-hemolytic streptococci: prevalence at four medical centers.

Authors:  J D Arthur; J F Keiser; S L Brown; J Higbee; C E Butler
Journal:  Pediatr Infect Dis       Date:  1984 Sep-Oct

7.  Erythromycin: a microbial and clinical perspective after 30 years of clinical use (1).

Authors:  J A Washington; W R Wilson
Journal:  Mayo Clin Proc       Date:  1985-03       Impact factor: 7.616

8.  Pharyngitis in adults: the presence and coexistence of viruses and bacterial organisms.

Authors:  P Huovinen; R Lahtonen; T Ziegler; O Meurman; K Hakkarainen; A Miettinen; P Arstila; J Eskola; P Saikku
Journal:  Ann Intern Med       Date:  1989-04-15       Impact factor: 25.391

Review 9.  Resurgence of rheumatic fever in the United States. The changing picture of a preventable illness.

Authors:  E M Ayoub
Journal:  Postgrad Med       Date:  1992-09-01       Impact factor: 3.840

10.  Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin.

Authors:  G R Istre; D F Welch; M I Marks; N Moyer
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.